Early and Sustained Clinical Benefits of Benralizumab in Severe Eosinophilic Asthma: Findings from the ORBE II Study. [PDF]
Ausín P +8 more
europepmc +1 more source
The Effect of Mepolizumab on Blood Eosinophil Subtype Distribution and Granule Protein Gene Expression in Severe Eosinophilic Asthma. [PDF]
Rimkunas A +6 more
europepmc +1 more source
Asthma and Multimorbidity Amongst Ethnic Minority Groups in High Income Countries
There is a tight intersection between asthma, deprivation, ethnicity, multimorbidity and poor clinical outcomes. An integrated, holistic and culturally tailored approach is needed to improve clinical outcomes amongst ethnic minority groups with asthma and multimorbidity. ABSTRACT Asthma is one of the commonest noncommunicable diseases worldwide.
Mamidipudi Thirumala Krishna +6 more
wiley +1 more source
Out of Breath, out of Options: Benralizumab as a Last Hope in ICU-Treated Near-Fatal Eosinophilic Asthma: A Case Series. [PDF]
Conemans L +4 more
europepmc +1 more source
Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatment. [PDF]
Pham DD +28 more
europepmc +1 more source
Autoimmune Mechanisms and Extracellular Traps in Non-eosinophilic Asthma. [PDF]
Hur GY.
europepmc +1 more source
Consensus from European experts on severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: Results from the OverSEA Delphi study. [PDF]
Bachert C +10 more
europepmc +1 more source
Mepolizumab: Which condition benefits more: Nasal polyps or eosinophilic asthma? [PDF]
Açar E +8 more
europepmc +1 more source

